<DOC>
	<DOC>NCT00180232</DOC>
	<brief_summary>The study tries to reveal if aminobisphosphonates influence aside the bone density also the vascular status in the typical elderly patient population</brief_summary>
	<brief_title>An Open Clinical Trial to Assess the Influence of Newly Prescribed Aminobiphosphonates on Arterial Stiffness</brief_title>
	<detailed_description>The subjects - starting bisphosphonate treatment due to medical reasons - will be additionally investigated as outpatients (arterial stiffness, applanation tonometry), for each subject 3 individual dates with a duration of approx. 30 min each are scheduled, prior to therapy with bisphosphonate, after 3 and 6 month of treatment</detailed_description>
	<mesh_term>Osteoporosis</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<criteria>Patients starting an aminobisphosphonate therapy due to medical reasons Brocaindex: between 20 and +25% who are willing and capable to confirm written consent to enrolment after ample information has been provided patients with major cardiovascular disease patients participating in another clinical trial 1month prior to inclusion in this study patients unable or unwilling to give informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2012</verification_date>
</DOC>